Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

[Cholesterol inhibitor and memantine in symptomatic dementia therapy].

Rodda J, Carter J.

Praxis (Bern 1994). 2013 Feb 27;102(5):293-300; discussion 298-9. doi: 10.1024/1661-8157/a001209. Review. German. No abstract available.

PMID:
23446240
[PubMed - indexed for MEDLINE]
2.

Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.

Masterman D.

Clin Geriatr Med. 2004 Feb;20(1):59-68. No abstract available.

PMID:
15062487
[PubMed - indexed for MEDLINE]
3.

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Lopez OL, Becker JT, Wahed AS, Saxton J, Sweet RA, Wolk DA, Klunk W, Dekosky ST.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):600-7. doi: 10.1136/jnnp.2008.158964. Epub 2009 Feb 9. Erratum in: J Neurol Neurosurg Psychiatry. 2009 Sep 1;80(9):1056.

PMID:
19204022
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Gallini A, Sommet A, Salandini AM, Veyssière P, Montastruc JL, Montastruc JL.

Mov Disord. 2007 Oct 15;22(13):1980-1. No abstract available.

PMID:
17657810
[PubMed - indexed for MEDLINE]
5.

[Medical treatment of Alzheimer's disease].

Johannsen P.

Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.

PMID:
17032609
[PubMed - indexed for MEDLINE]
6.

Treatment of Alzheimer disease.

Winslow BT, Onysko MK, Stob CM, Hazlewood KA.

Am Fam Physician. 2011 Jun 15;83(12):1403-12. Erratum in: Am Fam Physician. 2014 Aug 15;90(4):209.

PMID:
21671540
[PubMed - indexed for MEDLINE]
Free Article
7.

[Dementia].

Diehl RR.

Fortschr Neurol Psychiatr. 2003 Nov;71(11):617-28. Review. German. No abstract available.

PMID:
14608514
[PubMed - indexed for MEDLINE]
8.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Grossberg GT, Edwards KR, Zhao Q.

J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. Review.

PMID:
16809811
[PubMed - indexed for MEDLINE]
9.

[Modern therapy for dementia].

Padberg F, Möller HJ, Bottlender R, Hampel H.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:71-4, 76-7. German.

PMID:
15968877
[PubMed - indexed for MEDLINE]
10.

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Burns A, O'Brien J; BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology.

J Psychopharmacol. 2006 Nov;20(6):732-55. Review.

PMID:
17060346
[PubMed - indexed for MEDLINE]
11.

Memantine: a new approach to Alzheimer's disease.

Keltner NL, Williams B.

Perspect Psychiatr Care. 2004 Jul-Sep;40(3):123-4. No abstract available.

PMID:
15515294
[PubMed - indexed for MEDLINE]
12.

Alternative drug therapies for dementia.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 May;49(5):17-20. doi: 10.3928/02793695-20110407-03. Epub 2011 Apr 27.

PMID:
21553703
[PubMed - indexed for MEDLINE]
13.

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.

Jones RW.

Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53. doi: 10.1002/gps.2384. Review.

PMID:
20049770
[PubMed - indexed for MEDLINE]
14.

Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.

Doody R, Wirth Y, Schmitt F, Möbius HJ.

Dement Geriatr Cogn Disord. 2004;18(2):227-32. Epub 2004 Jul 14.

PMID:
15256834
[PubMed - indexed for MEDLINE]
15.

Memantine (Ebixa) in clinical practice - results of an observational study.

Calabrese P, Essner U, Forstl H.

Dement Geriatr Cogn Disord. 2007;24(2):111-7. Epub 2007 Jun 29.

PMID:
17622714
[PubMed - indexed for MEDLINE]
16.

Memantine in the treatment of dementia.

Maggiore C, Locatelli L, Grandi FC, Pizzolato G; Cochrane Neurological Network.

Neuroepidemiology. 2007;28(2):118-9. Epub 2007 Apr 4. No abstract available.

PMID:
17409774
[PubMed - indexed for MEDLINE]
17.

[Antidementia drugs].

Müller-Spahn F, Sollberger D, Wollmer MA.

Ther Umsch. 2009 Jun;66(6):432-40. doi: 10.1024/0040-5930.66.6.432. Review. German.

PMID:
19496039
[PubMed - indexed for MEDLINE]
18.

What is the rationale for new treatment strategies in Alzheimer's disease?

Rogawski MA.

CNS Spectr. 2004 Jul;9(7 Suppl 5):6-12.

PMID:
15241294
[PubMed - indexed for MEDLINE]
19.

[The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].

Damulin IV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(5):65-7. Russian. No abstract available.

PMID:
19938276
[PubMed - indexed for MEDLINE]
20.

[Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].

[No authors listed]

MMW Fortschr Med. 2003 Jun 5;145(23):60. German. No abstract available.

PMID:
12854234
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk